Risk in atrial fibrillation: left atrial function matters
Date
2019Language
en
Keyword
Abstract
[No abstract available]
Collections
Related items
Showing items related by title, author, creator and subject.
-
Ranolazine Added to Amiodarone Facilitates Earlier Conversion of Atrial Fibrillation Compared to Amiodarone-Only Therapy
Tsanaxidis N., Aidonidis I., Hatziefthimiou A., Daskalopoulou S.S., Giamouzis G., Triposkiadis F., Skoularigis I. (2017)Background: Amiodarone (AMIO) is for many years effectively used to control ventricular rate during atrial fibrillation (AF) and to convert it into sinus rhythm. However, due to its delayed onset of action, ranolazine ... -
Incident Atrial Fibrillation in Systemic Sclerosis: The Predictive Role of B-Type Natriuretic Peptide
Giallafos, I.; Triposkiadis, F.; Oikonomou, E.; Giamouzis, G.; Aggeli, K.; Konstantopoulou, P.; Kouranos, V.; Mavrikakis, M.; Giallafos, J.; Stefanadis, C.; Sfikakis, P. P. (2014)Introduction: Atrial fibrillation (AF) is common in patients with systemic sclerosis (SSc) and is associated with significant morbidity, mortality, and healthcare expenditures. The aim of this study was to prospectively ... -
Ranolazine depresses conduction of rapid atrial depolarizations in a beating rabbit heart model
Aidonidis I., Simopoulos V., Stravela S., Dipla K., Stamatiou R., Hatziefthimiou A., Molyvdas P.-A. (2021)Purpose: Previous clinical studies have shown that ranolazine (RAN) added to amiodarone (AMIO) might accelerate the termination of recent-onset atrial fibrillation. This study was undertaken to delineate possible mechanisms ...

